Vanderbilt Institute for Clinical and Translational Research (VICTR)

Gordon Bernard (Steve Green/Vanderbilt)
June 24, 2020

VICTR named to key role to streamline COVID-19 research response

The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.

By Bill Snyder
June 23, 2020

A connection to schizophrenia

The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.

By Bill Snyder
June 18, 2020

All of Us program launches cloud-based research platform

On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench.

By Paul Govern
April 23, 2020

VUMC team creates COVID-19 research registry

Out of the electronic health records (EHRs) of patients seen at Vanderbilt University Medical Center, a team in the Department of Biomedical Informatics is creating a COVID-19 patient registry as a platform for research.

By Paul Govern
January 16, 2020

Wilkins named CTSA co-principal investigator

Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.

By Bill Snyder
January 2, 2020

Chris Pua’s behind-the-scenes work brings him into spotlight

He hopes the software applications and systems he and his team develop work so well that users don’t even notice them.

By Leigh MacMillan
December 12, 2019

A new anti-seizure target?

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.
By Leigh MacMillan
October 3, 2019

Study: personalized decision support affects intensive care

For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.
By Paul Govern
October 2, 2019

Research team sorts out drug screen false positive results

Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone.
By Paul Govern
September 10, 2019

Relational memory in early psychosis

Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis.
By Kelsey Herbers
August 15, 2019

REDCap data management tool reaches million user mark

Fifteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has reached 1 million users throughout the world.
By Bill Snyder
July 11, 2019

Working memory in psychotic disorders

Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders.
By Kelsey Herbers
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan
1 2 3 4 5 6 … 8